Association between Class III Obesity (BMI of 40–59 kg/m2) and Mortality: A Pooled Analysis of 20 Prospective Studies
Summary
Background The prevalence of class III obesity (body mass index [BMI]≥40 kg/m2) has increased dramatically in several countries and currently affects 6% of adults in the US, with uncertain impact on the risks of illness and death. Using data from a large pooled study, we evaluated the risk of death, overall and due to a wide range of causes, and years of life expectancy lost associated with class III obesity. Methods and Findings In a pooled analysis of 20 prospective studies from the United States, Sweden, and Australia, we estimated sex- and age-adjusted total and cause-specific mortality rates (deaths per 100,000 persons per year) and multivariable-adjusted hazard ratios for adults, aged 19–83 y at baseline, classified as obese class III (BMI 40.0–59.9 kg/m2) compared with those classified as normal weight (BMI 18.5–24.9 kg/m2). Participants reporting ever smoking cigarettes or a history of chronic disease (heart disease, cancer, stroke, or emphysema) on baseline questionnaires were excluded. Among 9,564 class III obesity participants, mortality rates were 856.0 in men and 663.0 in women during the study period (1976–2009). Among 304,011 normal-weight participants, rates were 346.7 and 280.5 in men and women, respectively. Deaths from heart disease contributed largely to the excess rates in the class III obesity group (rate differences = 238.9 and 132.8 in men and women, respectively), followed by deaths from cancer (rate differences = 36.7 and 62.3 in men and women, respectively) and diabetes (rate differences = 51.2 and 29.2 in men and women, respectively). Within the class III obesity range, multivariable-adjusted hazard ratios for total deaths and deaths due to heart disease, cancer, diabetes, nephritis/nephrotic syndrome/nephrosis, chronic lower respiratory disease, and influenza/pneumonia increased with increasing BMI. Compared with normal-weight BMI, a BMI of 40–44.9, 45–49.9, 50–54.9, and 55–59.9 kg/m2 was associated with an estimated 6.5 (95% CI: 5.7–7.3), 8.9 (95% CI: 7.4–10.4), 9.8 (95% CI: 7.4–12.2), and 13.7 (95% CI: 10.5–16.9) y of life lost. A limitation was that BMI was mainly ascertained by self-report. Conclusions Class III obesity is associated with substantially elevated rates of total mortality, with most of the excess deaths due to heart disease, cancer, and diabetes, and major reductions in life expectancy compared with normal weight.
Key Points
- 1Class three obesity leads to significantly higher mortality rates compared to normal weight
- 2Major causes of excess mortality include heart disease, cancer, and diabetes
- 3The study combines data from multiple countries to provide a comprehensive analysis
- 4Individuals with higher BMI within the class three category face increased years of life lost
- 5The results underscore the urgent public health implications of rising obesity rates.
Related articles
Collection, Transport, Treatment, Storage, and Disposal of R2TMC Health Care Waste for CY 2027 by a DENR-EMB Accredited Transporter and TSD Facility
This document outlines the terms of reference for the collection, transport, treatment, storage, and disposal of healthcare waste for the Region II Trauma and Medical Center (R2TMC) by a DENR-EMB accredited transporter and treatment, storage, and disposal (TSD) facility for the year 2027.
How Do Nonsurgical Interventions Improve Pain and Physical Function in People With Osteoarthritis? A Scoping Review of Mediation Analysis Studies
This scoping review investigates the mediators of nonsurgical interventions aimed at improving pain and physical function in patients with osteoarthritis. By summarizing findings from various studies, the review seeks to clarify how specific interventions can affect outcomes such as pain relief and improved physical function.
Danish Register of Chronic Obstructive Pulmonary Disease
The document reviews the Danish Register of Chronic Obstructive Pulmonary Disease (DrCOPD), a nationwide database aimed at documenting and improving the treatment quality for COPD patients in Denmark. It details the dataset, patient demographics, and the database's objectives in enhancing COPD management.
Sperm DNA Fragmentation: A New Guideline for Clinicians
This review article discusses the significance of sperm DNA fragmentation and provides guidelines for clinicians on its assessment and management in relation to male infertility. It emphasizes the causes, implications, and clinical utility of sperm DNA testing based on recent scientific findings.
GASTROINTESTINAL AND HEPATOBILIARY SYSTEM DRUGS
This document provides an overview of various drugs affecting the gastrointestinal and hepatobiliary systems, detailing their classifications, mechanisms, and therapeutic uses. It aims to educate students on common medications available in the pharmaceutical market.